Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
Name | Respiratory Syncytial Virus (RSV) vaccine (bivalent, recombinant) powder and solvent for solution for injection 0.5ml vials |
BNF code | 1404000AWAAABAB |
Virtual Therapeutic Moiety | Respiratory Syncytial Virus (RSV) vaccine |
Abbreviated name | Respiratory Syncytial Virus (RSV) vacc (bivalent, rcmb) inj |
Basis of preferred name | Other |
Prescribing status | Valid as a prescribable product |
Sugar free | ✗ |
Gluten free | ✗ |
Preservative free | ✗ |
CFC free | ✗ |
Dose form | Discrete |
Unit dose form size | 0.500 |
Unit dose form units | ml |
Unit dose unit of measure | vial |
Virtual Product Ingredient | |
---|---|
Ingredient | Respiratory Syncytial Virus recombinant glycoprotein F (RSVPreF) subgroup B |
Virtual Product Ingredient | |
Ingredient | Respiratory Syncytial Virus recombinant glycoprotein F (RSVPreF) subgroup A |
Ontology Drug Form & Route | |
Form & Route | solutioninjection.intramuscular |
Dose Form | |
Formulation | Powder and solvent for solution for injection |
Drug Route | |
Route | Intramuscular |
Controlled Drug Prescribing Information | |
Controlled Drug category | No Controlled Drug Status |
Actual Medicinal Products | |
Abrysvo vaccine powder and solvent for solution for injection 0.5ml vials (Pfizer Ltd) | |
Virtual Medicinal Product Packs | |
Respiratory Syncytial Virus (RSV) vaccine (bivalent, recombinant) powder and solvent for solution for injection 0.5ml vials 1 vial |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.